Progressive loss of cones in achromatopsia: an imaging study using spectral-domain optical coherence tomography.
暂无分享,去创建一个
C. Klaver | F. Cremers | C. Hoyng | R. Kuijpers | S. Roosing | C. Klaver | L. I. van den Born | A. Thiadens | V. Somervuo | M. V. van Schooneveld | Norka van Moll-Ramirez | L. I. Born | M. Schooneveld | N. V. Moll-Ramirez | Robert W.A.M. Kuijpers | Ahj Thiadens | PM Frans | Cremers
[1] R. Ali,et al. AAV-mediated gene therapy for retinal disorders: from mouse to man , 2008, Gene Therapy.
[2] Teresa C. Chen,et al. In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography. , 2004, Optics letters.
[3] G. Holmström,et al. Optical coherence tomography is helpful in the diagnosis of foveal hypoplasia , 2009, Acta ophthalmologica.
[4] C. Klaver,et al. Homozygosity mapping reveals PDE6C mutations in patients with early-onset cone photoreceptor disorders. , 2009, American journal of human genetics.
[5] G. Somfai,et al. Optical coherence tomography of the macula in congenital achromatopsia. , 2007, Investigative ophthalmology & visual science.
[6] A. Hendrickson,et al. The foveal avascular region of developing human retina. , 2008, Archives of ophthalmology.
[7] J. Izatt,et al. Abnormal foveal morphology in ocular albinism imaged with spectral-domain optical coherence tomography. , 2009, Archives of ophthalmology.
[8] W. Hauswirth,et al. Achromatopsia as a potential candidate for gene therapy. , 2010, Advances in experimental medicine and biology.
[9] M. Alpern,et al. Typical total monochromacy. A histological and psychophysical study. , 1965, Archives of ophthalmology.
[10] P. Sieving,et al. Mutations in the CNGB3 gene encoding the beta-subunit of the cone photoreceptor cGMP-gated channel are responsible for achromatopsia (ACHM3) linked to chromosome 8q21. , 2000, Human molecular genetics.
[11] M. Seeliger,et al. Selective loss of cone function in mice lacking the cyclic nucleotide-gated channel CNG3. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Fujimoto,et al. Ultrahigh-resolution ophthalmic optical coherence tomography , 2001, Nature Medicine.
[13] F. Sutter,et al. Quantitative analysis of OCT characteristics in patients with achromatopsia and blue-cone monochromatism. , 2006, Investigative ophthalmology & visual science.
[14] D. Hunt,et al. Progressive cone and cone-rod dystrophies: phenotypes and underlying molecular genetic basis. , 2006, Survey of ophthalmology.
[15] M. Glickstein,et al. Receptors in the monochromat eye , 1975, Vision Research.
[16] S. Jacobson,et al. CNGA3 mutations in hereditary cone photoreceptor disorders. , 2001, American journal of human genetics.
[17] W. Hauswirth,et al. Restoration of cone vision in a mouse model of achromatopsia , 2007, Nature Medicine.
[18] Vikram S Brar,et al. Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis). , 2009, American journal of ophthalmology.
[19] S. Jacobson,et al. Mutations in the cone photoreceptor G-protein alpha-subunit gene GNAT2 in patients with achromatopsia. , 2002, American journal of human genetics.
[20] Veit Sturm,et al. Reproducibility of retinal thickness measurements in healthy subjects using spectralis optical coherence tomography. , 2009, American journal of ophthalmology.
[21] J. N. Hayward,et al. Congenital total color blindness: a clincopathological report. , 1960, Archives of ophthalmology.
[22] F L Ferris,et al. Photocoagulation for diabetic macular edema. , 1987, Archives of ophthalmology.
[23] Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. , 1985, Archives of ophthalmology.
[24] S. Haverkamp,et al. Impaired opsin targeting and cone photoreceptor migration in the retina of mice lacking the cyclic nucleotide-gated channel CNGA3. , 2005, Investigative ophthalmology & visual science.